These inhibitors function by blocking the interaction between PD-1 and PD-L1, thereby activating cytotoxic T lymphocytes, relieving immune suppression, enhancing the host immune response against tumor cells, and effectively inhibiting tumor growth and metastasis (3, 4). Here, PDCD1 is linked to neoplasm.